BD NANO¿ 2ND GEN PEN NEEDLE
Report
- Report Number
- 2243072-2022-00162
- Event Type
- Malfunction
- Date Received
- February 7, 2022
- Date of Event
- January 25, 2022
- Report Date
- May 16, 2024
- Manufacturer
- BECTON DICKINSON AND CO.
- Product Code
- FMI
- UDI-DI
- 10885403928659
- PMA / PMN Number
- K162516
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PA, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
DATE OF EVENT: UNKNOWN. MEDICAL DEVICE EXPIRATION DATE: UNKNOWN. A DEVICE EVALUATION IS ANTICIPATED BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED. DEVICE MANUFACTURE DATE: UNKNOWN.
THE FOLLOWING FIELDS WERE UPDATED DUE TO ADDITIONAL INFORMATION: D1: MEDICAL DEVICE BRAND NAME: BD NANO¿ 2ND GEN PEN NEEDLE. D3: MEDICAL DEVICE MANUFACTURER: BECTON DICKINSON AND CO. D4 UDI: (B)(4). THERE WERE MULTIPLE LOT NUMBERS REPORTED TO BE INVOLVED. THE INFORMATION FOR EACH ADDITIONAL LOT NUMBER IS AS FOLLOWS: D4. MEDICAL DEVICE LOT #: 1006162. D4. MEDICAL DEVICE EXPIRATION DATE: 31JAN2026. H4. DEVICE MANUFACTURE DATE: 12MAR2021. D4. MEDICAL DEVICE LOT #: 0303291. D4. MEDICAL DEVICE EXPIRATION DATE: 30NOV2025. H4. DEVICE MANUFACTURE DATE: 17DEC2020. D4. MEDICAL DEVICE LOT #: 0287396. D4. MEDICAL DEVICE EXPIRATION DATE: 31OCT2025. H4. DEVICE MANUFACTURE DATE: 13OCT2020. G1: MANUFACTURING LOCATION: BECTON DICKINSON AND CO. G5: PMA/510(K)# K162516. D9: DEVICE AVAILABLE FOR EVAL YES. D9: RETURNED TO MANUFACTURER ON: 07FEB2022. H.6. INVESTIGATION SUMMARY: SAMPLES WERE RECEIVED AND AN INVESTIGATION WAS PERFORMED. THIS IS THE 1ST RELATED COMPLAINT FOR THE REPORTED LOT NUMBER1006162. THIS IS THE 4TH RELATED COMPLAINT FOR THE REPORTED LOT NUMBER 0287396 AND 0303291. A REVIEW OF THE MANUFACTURING RECORDS WAS PERFORMED AND NO NON-CONFORMANCES WERE RAISED IN ASSOCIATION WITH THIS TYPE OF EVENT FOR THIS LOT. BD WAS ABLE TO DUPLICATE OR CONFIRM THE INDICATED ISSUE AND BASED ON TREND ANALYSIS NO FURTHER ACTION IS REQUIRED AT THIS TIME. COMPLAINTS RECEIVED FOR THIS DEVICE AND REPORTED CONDITION WILL CONTINUE TO BE TRACKED AND TRENDED. BASED ON THE ABOVE, NO ADDITIONAL INVESTIGATION AND NO CORRECTIVE/PREVENTATIVE ACTION (CAPA) OR SITUATION ANALYSIS (SA) IS REQUIRED AT THIS TIME.
IT WAS REPORTED THAT AN UNSPECIFIED BD PEN NEEDLE WAS UNABLE TO DELIVER INSULIN. THE PATIENT HAD TO USE A SECOND PEN NEEDLE TO COMPLETE INJECTION. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: WHEN TAKING INJECTION, THE FLOW WILL STOP BEFORE THE COMPLETE DOSE IS COMPLETE.
IT WAS REPORTED THAT AN BD NANO¿ 2ND GEN PEN NEEDLE WAS UNABLE TO DELIVER INSULIN. THE PATIENT HAD TO USE A SECOND PEN NEEDLE TO COMPLETE INJECTION. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: WHEN TAKING INJECTION, THE FLOW WILL STOP BEFORE THE COMPLETE DOSE IS COMPLETE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 489155 | BD NANO¿ 2ND GEN PEN NEEDLE | HYPODERMIC SINGLE LUMEN NEEDLE | FMI | BECTON DICKINSON AND CO. | SEE H.10 | 10885403928659 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown |